Structure |
Chemical Name |
CAS |
MF |
![Posaconazole Impurity 9](/) |
Posaconazole Impurity 9 |
|
|
![Roxithromycin Impurity E](/) |
Roxithromycin Impurity E |
|
|
![SofosBuvir impurity 48](/) |
SofosBuvir impurity 48 |
|
|
![SofosBuvir Impurity 54](/CAS/20210111/GIF/1431932-81-8.gif) |
SofosBuvir Impurity 54 |
1431932-81-8 |
C12H17ClNO4P |
![Timolol EP Impurity G](/CAS/20180808/GIF/75202-36-7.gif) |
Timolol EP Impurity G |
75202-36-7 |
C6H9N3O3S |
![Tofacitinib Impurity 44](/CAS/20210305/GIF/2374700-39-5.gif) |
Tofacitinib Impurity 44 |
2374700-39-5 |
C13H19N5 |
![Trelagliptin Impurity 24](/) |
Trelagliptin Impurity 24 |
|
|
![dimethyl 3- isobutylpentanedioate](/CAS/20180703/GIF/CB73363727.gif) |
dimethyl 3- isobutylpentanedioate |
145328-03-6 |
C11H20O4 |
![Phenol, 4-chloro-3-[(4-ethoxyphenyl)methyl]-](/CAS/20180601/GIF/1408077-50-8.gif) |
Phenol, 4-chloro-3-[(4-ethoxyphenyl)methyl]- |
1408077-50-8 |
C15H15ClO2 |
![2-amino-9-((3aS,4S,6S,6aR)-3a,6-dihydroxyhexahydro-1H-cyclopenta[c]furan-4-yl)-1,9-dihydro-6H-purin-6-one](/CAS/20180601/GIF/1984788-96-6.gif) |
2-amino-9-((3aS,4S,6S,6aR)-3a,6-dihydroxyhexahydro-1H-cyclopenta[c]furan-4-yl)-1,9-dihydro-6H-purin-6-one |
1984788-96-6 |
C12H15N5O4 |
![Ampicillin Impurity C](/) |
Ampicillin Impurity C |
|
|
![Ampicillin Impurity O](/) |
Ampicillin Impurity O |
|
|
![(4R,5R,6S)-4-nitrobenzyl 6-((R)-1-hydroxyethyl)-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate](/CAS/20180601/GIF/104873-15-6.gif) |
(4R,5R,6S)-4-nitrobenzyl 6-((R)-1-hydroxyethyl)-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate |
104873-15-6 |
C17H18N2O7 |
![Lesinurad Impurity](/) |
Lesinurad Impurity |
|
|
![7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-(5-chloro-2-ethoxyphenyl)-1,6-dihydro-1-methyl-3-propyl-](/CAS/20180601/GIF/1829588-57-9.gif) |
7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-(5-chloro-2-ethoxyphenyl)-1,6-dihydro-1-methyl-3-propyl- |
1829588-57-9 |
C17H19ClN4O2 |
![Cefminox sodium impurities Ⅲ](/) |
Cefminox sodium impurities Ⅲ |
|
|
![Canagliflozin Impurity 18](/CAS/20211123/GIF/1951467-29-0.gif) |
Canagliflozin Impurity 18 |
1951467-29-0 |
C24H25FO6S |
![Fosaprepitant Impurity 6](/CAS/20210111/GIF/327623-34-7.gif) |
Fosaprepitant Impurity 6 |
327623-34-7 |
C21H19F6NO3 |
![Ivabradine Impurity 16 HCl](/CAS/20180808/GIF/304464-98-0.gif) |
Ivabradine Impurity 16 HCl |
304464-98-0 |
C26H34N2O5 |
![Moxifloxacin EP Impurity A HCl](/) |
Moxifloxacin EP Impurity A HCl |
|
|
![Paroxetine EP Impurity H HCl](/CAS/20211123/GIF/503834-41-1.gif) |
Paroxetine EP Impurity H HCl |
503834-41-1 |
C19H23ClFNO |
![Solifenacin Related Compound 13](/CAS/20210111/GIF/1251905-45-9.gif) |
Solifenacin Related Compound 13 |
1251905-45-9 |
C17H17NO2 |
![1-(3-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide](/CAS/20180601/GIF/2101651-50-5.gif) |
1-(3-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide |
2101651-50-5 |
C14H12FN5 |
![N1-(4-chlorophenyl)-3,12-diimino-N14-phenyl-2,4,11,13-Tetraazatetradecanediimidamide](/CAS/20200611/GIF/152504-12-6.gif) |
N1-(4-chlorophenyl)-3,12-diimino-N14-phenyl-2,4,11,13-Tetraazatetradecanediimidamide |
152504-12-6 |
C22H31ClN10 |
![Ethylmethyl-carbamic chloride](/CAS/GIF/42252-34-6.gif) |
Ethylmethyl-carbamic chloride |
42252-34-6 |
C4H8ClNO |
![Cisatracurium-20-methyl Dibenzenesulfonate](/CAS/20211123/GIF/1193104-85-6.gif) |
Cisatracurium-20-methyl Dibenzenesulfonate |
1193104-85-6 |
C60H79N2O15S+ |
![[R-(R*,S*)]-(-)-N-(1-PHENYLETHYL)-1-AZABICYCLO[2.2.2]OCTAN-3-AMINE DIHYDROCHLORIDE](/CAS/GIF/128311-06-8.gif) |
[R-(R*,S*)]-(-)-N-(1-PHENYLETHYL)-1-AZABICYCLO[2.2.2]OCTAN-3-AMINE DIHYDROCHLORIDE |
128311-06-8 |
C15H24Cl2N2 |
![GURKHSYORGJETM-MGDILKBHSA-N](/CAS/20211123/GIF/1992961-26-8.gif) |
GURKHSYORGJETM-MGDILKBHSA-N |
1992961-26-8 |
C33H39ClN4O6 |
![DVCUGHHGLKCBMT-QVDQXJPCSA-N](/CAS/20211123/GIF/1356353-76-8.gif) |
DVCUGHHGLKCBMT-QVDQXJPCSA-N |
1356353-76-8 |
C15H24N6O6 |
![5,6-Dehydro-Tigecycline](/CAS/20210111/GIF/1633815-62-9.gif) |
5,6-Dehydro-Tigecycline |
1633815-62-9 |
C29H37N5O8 |
![2,3,5,6-tetradeuterio-4-[5-[4-(hydroxymethyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide](/CAS/20180601/GIF/1276524-56-1.gif) |
2,3,5,6-tetradeuterio-4-[5-[4-(hydroxymethyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide |
1276524-56-1 |
C17H10D4F3N3O3S |
![1,1-diphenylpropan-1-ol](/CAS/20180601/GIF/5180-33-6.gif) |
1,1-diphenylpropan-1-ol |
5180-33-6 |
C15H16O |
![(R)-De(trifluoromethyl) Fluoxetine Hydrochloride](/CAS/20180808/GIF/1212215-97-8.gif) |
(R)-De(trifluoromethyl) Fluoxetine Hydrochloride |
1212215-97-8 |
C16H20ClNO |
![(1R,5S)-1-phenyl-3-oxabicyclo[3.1.0]hexan-2-one](/CAS/20180601/GIF/96847-52-8.gif) |
(1R,5S)-1-phenyl-3-oxabicyclo[3.1.0]hexan-2-one |
96847-52-8 |
C11H10O2 |
![12-ethyl-8-methyl-9-oxo-7-propionyl-9,11-dihydroindolizino[1,2-b]quinolin-2-yl [1,4'-bipiperidine]-1'-carboxylate](/CAS/20180703/GIF/176515-52-9.gif) |
12-ethyl-8-methyl-9-oxo-7-propionyl-9,11-dihydroindolizino[1,2-b]quinolin-2-yl [1,4'-bipiperidine]-1'-carboxylate |
176515-52-9 |
C32H38N4O4 |
![4-amino-5-chloro-N-(1-propylpiperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide](/CAS/20180703/GIF/CB73956017.gif) |
4-amino-5-chloro-N-(1-propylpiperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide |
|
C17H24ClN3O2 |
![Ceftazidime Impurity D](/) |
Ceftazidime Impurity D |
|
|
![Ceftazidime Sulfoxide Impurity](/) |
Ceftazidime Sulfoxide Impurity |
|
|
![Tofacitinib Impurity Y](/) |
Tofacitinib Impurity Y |
|
|
![5-amino-6-chloro-2-(propylthio)pyrimidin-4-ol](/CAS/20180703/GIF/CB74033438.gif) |
5-amino-6-chloro-2-(propylthio)pyrimidin-4-ol |
|
C7H10ClN3OS |
![Labetalol EP impurity G](/) |
Labetalol EP impurity G |
|
|
![2-(2-NITROPHENYL)ETHANAMINE](/CAS/GIF/33100-15-1.gif) |
2-(2-NITROPHENYL)ETHANAMINE |
33100-15-1 |
C8H10N2O2 |
![CLOZAPINE-D3](/CAS/20211123/GIF/1215691-72-7.gif) |
CLOZAPINE-D3 |
1215691-72-7 |
C18H19ClN4 |
![Bendamustine Impurity 25](/) |
Bendamustine Impurity 25 |
|
|
![Canagliflozin Impurity 25](/) |
Canagliflozin Impurity 25 |
|
|
![Edoxaban Impurity 41](/CAS/20210111/GIF/1353893-25-0.gif) |
Edoxaban Impurity 41 |
1353893-25-0 |
C14H27N3O3 |
![Istradefylline Impurity 5](/) |
Istradefylline Impurity 5 |
|
|
![Milrinone Impurity 10](/) |
Milrinone Impurity 10 |
|
|
![Olanzapine Impurity 3](/CAS/20200401/GIF/CB74631933.gif) |
Olanzapine Impurity 3 |
|
C17H20N4S |
![Ticagrelor Related Compound 54](/) |
Ticagrelor Related Compound 54 |
|
|
![Blonanserin Impurity N](/) |
Blonanserin Impurity N |
|
|
![Brexpiprazole Impurity N](/) |
Brexpiprazole Impurity N |
|
|
![Cefaclor Impurity 1](/) |
Cefaclor Impurity 1 |
|
|
![Cefminox Sodium impurity 4](/) |
Cefminox Sodium impurity 4 |
|
|
![Cefradine Impurity B](/) |
Cefradine Impurity B |
|
|
![Dapoxetine Impurity F](/) |
Dapoxetine Impurity F |
|
|
![Olaparib Impurity E](/) |
Olaparib Impurity E |
|
|
![Cefathiamidine Impurity 6](/CAS/20210111/GIF/28240-16-6.gif) |
Cefathiamidine Impurity 6 |
28240-16-6 |
C12H13ClN2O6S |
![rac-2,2'-(((3aR,3a'R,4R,4'R,6S,6aS,6'S,6a'S)-((5-nitro-2-(propylthio)pyrimidine-4,6-diyl)bis(azanediyl))bis(2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxole-6,4-diyl))bis(oxy))bis(ethan-1-ol)](/CAS/20211123/GIF/1882095-50-2.gif) |
rac-2,2'-(((3aR,3a'R,4R,4'R,6S,6aS,6'S,6a'S)-((5-nitro-2-(propylthio)pyrimidine-4,6-diyl)bis(azanediyl))bis(2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxole-6,4-diyl))bis(oxy))bis(ethan-1-ol) |
1882095-50-2 |
C27H43N5O10S |
![3R,4S-4-(4-methoxyphenyl)-1-methylpiperi
dinyl] methanol](/CAS/20200611/GIF/127017-78-1.gif) |
3R,4S-4-(4-methoxyphenyl)-1-methylpiperi
dinyl] methanol |
127017-78-1 |
C14H21NO2 |
![6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(1R,3S,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-](/CAS/GIF/188399-46-4.gif) |
6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(1R,3S,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]- |
188399-46-4 |
C12H15N5O3 |
![Valsartan cyano analog methyl ester](/CAS/GIF/137863-90-2.gif) |
Valsartan cyano analog methyl ester |
137863-90-2 |
C25H30N2O3 |
![(8S)-2-BroMo α-Ergocryptine](/CAS/GIF/65700-36-9.gif) |
(8S)-2-BroMo α-Ergocryptine |
65700-36-9 |
C32H40BrN5O5 |
![3-[4-(4-Chlorobenzoyl)phenoxy]-2-butanone (Fenofibrate IMpurity)](/CAS/GIF/217636-47-0.gif) |
3-[4-(4-Chlorobenzoyl)phenoxy]-2-butanone (Fenofibrate IMpurity) |
217636-47-0 |
C17H15ClO3 |
![5-(2-Chlorobenzyl)-thieno[3,2-c]pyridiniuM Chloride](/CAS/GIF/53885-64-6.gif) |
5-(2-Chlorobenzyl)-thieno[3,2-c]pyridiniuM Chloride |
53885-64-6 |
C14H11Cl2NS |
![ClarithroMycin 9-OxiMe](/CAS/GIF/103450-87-9.gif) |
ClarithroMycin 9-OxiMe |
103450-87-9 |
C38H70N2O13 |
![Desloratadine N-Hydroxypiperidine](/CAS/GIF/1193725-73-3.gif) |
Desloratadine N-Hydroxypiperidine |
1193725-73-3 |
C19H19ClN2O |
![O-DesMethyl Venlafaxine Cyclic IMpurity](/CAS/20140608/GIF/CB92544073.gif) |
O-DesMethyl Venlafaxine Cyclic IMpurity |
1346601-55-5 |
C16H23NO2 |
![rac-cis-2,3-Dichloro Sertraline Hydrochloride](/CAS/GIF/1198084-29-5.gif) |
rac-cis-2,3-Dichloro Sertraline Hydrochloride |
1198084-29-5 |
C17H18Cl3N |
![11β-Hydroperoxy Dienogest](/CAS/GIF/106111-43-7.gif) |
11β-Hydroperoxy Dienogest |
106111-43-7 |
C20H25NO4 |
![2'-Nor ThiaMine](/CAS/GIF/7770-93-6.gif) |
2'-Nor ThiaMine |
7770-93-6 |
C11H15ClN4OS |
![6α-Methyl Hydrocortisone 21-Acetate](/CAS/GIF/1625-11-2.gif) |
6α-Methyl Hydrocortisone 21-Acetate |
1625-11-2 |
C24H34O6 |
![N1-Losartanyl-losartan (Losartan IMpurity)](/CAS/20150408/GIF/230971-71-8.gif) |
N1-Losartanyl-losartan (Losartan IMpurity) |
230971-71-8 |
C44H44Cl2N12O |
![N2-Losartanyl-losartan (Losartan IMpurity)](/CAS/20150408/GIF/230971-72-9.gif) |
N2-Losartanyl-losartan (Losartan IMpurity) |
230971-72-9 |
C44H44Cl2N12O |
![N-Ethoxycarbonyl 7-ADCA](/CAS/GIF/72820-16-7.gif) |
N-Ethoxycarbonyl 7-ADCA |
72820-16-7 |
C11H14N2O5S |
![4-PyridinecarboxaMide, N-(2,6-diMethylphenyl)-](/CAS/GIF/68280-05-7.gif) |
4-PyridinecarboxaMide, N-(2,6-diMethylphenyl)- |
68280-05-7 |
C14H14N2O |
![4-N-Desacetyl-5-N-acetyl OseltaMivir](/CAS/GIF/956267-10-0.gif) |
4-N-Desacetyl-5-N-acetyl OseltaMivir |
956267-10-0 |
C16H28N2O4 |
![rac N-DesMethyl-N-(4-Methoxyphenethyl) Venlafaxine](/CAS/20140608/GIF/CB92551075.gif) |
rac N-DesMethyl-N-(4-Methoxyphenethyl) Venlafaxine |
1346601-14-6 |
C25H35NO3 |
![11-Keto Oxcarbazepine](/CAS/20150408/GIF/537693-29-1.gif) |
11-Keto Oxcarbazepine |
537693-29-1 |
C15H10N2O3 |
![Isopropyl 4-(3-AMinophenyl)-1,4-dihydro-5-(2-Methoxyethoxycarbonyl)-2,6-diMethylpyridine-3-carboxylate](/CAS/GIF/155861-24-8.gif) |
Isopropyl 4-(3-AMinophenyl)-1,4-dihydro-5-(2-Methoxyethoxycarbonyl)-2,6-diMethylpyridine-3-carboxylate |
155861-24-8 |
C21H28N2O5 |
![(E)-Olopatadine](/CAS/20180808/GIF/113806-06-7.gif) |
(E)-Olopatadine |
113806-06-7 |
C21H23NO3 |
![NeMadipine B](/CAS/GIF/79925-38-5.gif) |
NeMadipine B |
79925-38-5 |
C19H21Cl2NO4 |
![N-[(3,4-DiMethoxy-2-pyridinyl)Methyl] Pantoprazole](/CAS/GIF/957470-59-6.gif) |
N-[(3,4-DiMethoxy-2-pyridinyl)Methyl] Pantoprazole |
957470-59-6 |
C24H24F2N4O6S |
![4-Epi-6-epi Doxycycline](/CAS/GIF/97583-08-9.gif) |
4-Epi-6-epi Doxycycline |
97583-08-9 |
C22H24N2O8 |
![Ethyl 3,4-O-Isopropylidene-5-O-methanesulfonylshikimate](/CAS/20200401/GIF/204254-84-2.gif) |
Ethyl 3,4-O-Isopropylidene-5-O-methanesulfonylshikimate |
204254-84-2 |
C13H20O7S |
![2-PyrazinecarboxaMide, N,N',N''-[2,4,6-boroxintriyltris[[(1R)-3-Methylbutylidene]iMino[(1S)-2-oxo-1-(phenylMethyl)-2,1-ethanediyl]]]tris-](/CAS/20180808/GIF/390800-88-1.gif) |
2-PyrazinecarboxaMide, N,N',N''-[2,4,6-boroxintriyltris[[(1R)-3-Methylbutylidene]iMino[(1S)-2-oxo-1-(phenylMethyl)-2,1-ethanediyl]]]tris- |
390800-88-1 |
C57H69B3N12O9 |
![Salmeterol Related Compound B (10 mg) (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2-(hydroxymethyl)phenol)](/CAS/GIF/108928-81-0.gif) |
Salmeterol Related Compound B (10 mg) (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2-(hydroxymethyl)phenol) |
108928-81-0 |
C25H37NO4 |
![N-[3-[3-(1-Piperidinylmethyl)phenoxy]propyl]amine](/CAS/GIF/73278-98-5.gif) |
N-[3-[3-(1-Piperidinylmethyl)phenoxy]propyl]amine |
73278-98-5 |
C15H24N2O |
![7,10-Bis-O-(2,2,2-trichloroethoxycarbonyl)-10-deacetylbaccatin III](/CAS/GIF/95603-44-4.gif) |
7,10-Bis-O-(2,2,2-trichloroethoxycarbonyl)-10-deacetylbaccatin III |
95603-44-4 |
C35H38Cl6O14 |
![4-(3-AMino-phenyl)-Morpholin-3-one](/CAS/GIF/1082495-22-4.gif) |
4-(3-AMino-phenyl)-Morpholin-3-one |
1082495-22-4 |
C10H12N2O2 |
![piperacillinylaMpicillin](/) |
piperacillinylaMpicillin |
|
|
![Celecoxib iMpurity-B](/) |
Celecoxib iMpurity-B |
|
|
![EMtricitabine iMpurity B](/) |
EMtricitabine iMpurity B |
|
|
![(S,S)-1,7-diazatricyclo[7.3.0.07,11]dodecane-2,6,8,12-tetrone](/CAS/GIF/14842-41-2.gif) |
(S,S)-1,7-diazatricyclo[7.3.0.07,11]dodecane-2,6,8,12-tetrone |
14842-41-2 |
C10H10N2O4 |
![BroMhexine Hydrochloride iMpurity DN-(2-AMino-5-broMobenzyl)-N-MethylcyclohexanaMine Dihydrochloride](/CAS/20130318/GIF/CB92617054.gif) |
BroMhexine Hydrochloride iMpurity DN-(2-AMino-5-broMobenzyl)-N-MethylcyclohexanaMine Dihydrochloride |
132004-28-5 |
C14H21BrN2 |
![2-(DiMethylcarbaMoyl)benzoic acid, 97%](/CAS/GIF/20320-37-0.gif) |
2-(DiMethylcarbaMoyl)benzoic acid, 97% |
20320-37-0 |
C10H11NO3 |
![RAC DESMETHYL CITALOPRAM HYDROCHLORIDE](/CAS/GIF/97743-99-2.gif) |
RAC DESMETHYL CITALOPRAM HYDROCHLORIDE |
97743-99-2 |
C19H19FN2O |
![2-Demethoxy-4-methoxy urapidil](/CAS/GIF/34661-79-5.gif) |
2-Demethoxy-4-methoxy urapidil |
34661-79-5 |
C20H29N5O3 |
![Ribavirin IMpurity F](/CAS/20211123/GIF/58151-87-4.gif) |
Ribavirin IMpurity F |
58151-87-4 |
C10H14N4O6 |
![4-[-((-((4-(5-(Bis(2-hydroxyethyl)aMino)-1-Methyl-1H-benzo[d]iMidazol-2-yl)butanoyl)oxy)ethyl)(2-hydroxyethyl)aMino)-1-Methyl-1H-benzo[d]iMidazol-2-yl)butanic Acid](/CAS/GIF/1228551-91-4.gif) |
4-[-((-((4-(5-(Bis(2-hydroxyethyl)aMino)-1-Methyl-1H-benzo[d]iMidazol-2-yl)butanoyl)oxy)ethyl)(2-hydroxyethyl)aMino)-1-Methyl-1H-benzo[d]iMidazol-2-yl)butanic Acid |
1228551-91-4 |
C32H41Cl3N6O4 |